The amyloid-b peptide (Ab) is a key protein in Alzheimer's disease (AD) pathology. We previously reported in vitro evidence suggesting that Ab is an antimicrobial peptide. We present in vivo data showing that Ab expression protects against fungal and bacterial infections in mouse, nematode, and cell culture models of AD. We show that Ab oligomerization, a behavior traditionally viewed as intrinsically pathological, may be necessary for the antimicrobial activities of the peptide. Collectively, our data are consistent with a model in which soluble Ab oligomers first bind to microbial cell wall carbohydrates via a heparin-binding domain. Developing protofibrils inhibited pathogen adhesion to host cells. Propagating b-amyloid fibrils mediate agglutination and eventual entrapment of unatttached microbes. Consistent with our model, Salmonella Typhimurium bacterial infection of the brains of transgenic 5XFAD mice resulted in rapid seeding and accelerated b-amyloid deposition, which closely colocalized with the invading bacteria. Our findings raise the intriguing possibility that b-amyloid may play a protective role in innate immunity and infectious or sterile inflammatory stimuli may drive amyloidosis. These data suggest a dual protective/damaging role for Ab, as has been described for other antimicrobial peptides.
INTRODUCTION
Neurodegeneration in Alzheimer's disease (AD) is mediated by soluble oligomeric intermediates generated during fibrillization of the amyloidb protein (Ab) (1) . Overwhelming evidence supports Ab's pivotal role in AD. However, despite remarkably high sequence conservation across diverse species (humans share Ab42 sequences with coelacanths, a 400 million-year-old fish taxon) (2) and extensive data showing broad activity spectra for Ab, the peptide has traditionally been characterized as a functionless catabolic byproduct. Activities identified for Ab in vivo are most often described as stochastic pathological behaviors. Oligomerization, in particular, is viewed as a pathogenic pathway, and Ab oligomers are assumed to be intrinsically abnormal. Scant consideration has been given to possible physiological roles for Ab.
Members of the evolutionarily ancient family of proteins, collectively known as antimicrobial peptides (AMPs), share many of Ab's purportedly abnormal activities, including oligomerization and fibrillization (3, 4) . For AMPs, these activities mediate key protective roles in innate immunity. AMPs are the first line of defense against pathogens and act as potent broad-spectrum antibiotics and immunomodulators that target bacteria, mycobacteria, enveloped viruses, fungi, protozoans, and, in some cases, transformed or cancerous host cells (5) . AMPs are widely expressed and are abundant in brain and other immunoprivileged tissues where actions of the adaptive immune system are constrained. Although AMPs are normally protective, AMP dysregulation can lead to host cell toxicity, chronic inflammation, and degenerative pathologies (6) (7) (8) . Particularly germane to Ab's role in AD, AMPs are deposited as amyloid in several disorders (3, 4, 9) , including senile seminal vesicle amyloid and isolated atrial amyloidosis, two of the most common human amyloidopathies. Consistent with identity as an AMP, we recently reported that synthetic Ab exhibits potent in vitro antimicrobial activity toward eight common and clinically relevant microbial pathogens (3) . Furthermore, whole-brain homogenates from AD patients show Ab-mediated activity against Candida albicans. More recently, synthetic Ab has been shown to protect cultured cells from influenza A virus (10) and herpes simplex virus (11) . However, the biological relevance of protective in vitro Ab activities requires validation in vivo. Here, we extend our original findings and show that Ab expression inhibits infection in a transgenic mouse model of AD (5XFAD), in the nematode Caenorhabditis elegans, and in cultured mammalian cell models. Mice lacking the amyloid precursor protein (APP) that have low Ab expression also show a trend toward attenuated survival after bacterial infection. Most surprisingly, oligomerization and fibrillization appear to mediate Ab's protective activity, and cerebral infection with microbial cells seeds and markedly accelerates b-amyloid deposition in 5XFAD mice and transgenic C. elegans.
of neuroinflammation found in older animals (12) . APP knockout (APP-KO) mice lack the precursor protein required for murine Ab generation (13) . One-month-old 5XFAD mice (n = 12), APP-KO mice (n = 15), and wild-type littermates (n = 11 and 15, respectively) received a single intracerebral injection of 65,000 colony-forming units (CFU) of S. Typhimurium. Clinical progression to the moribund state was followed according to established grading criteria for mouse encephalomyelitis ( fig. S1A ). Survival of Ab-expressing 5XFAD mice was significantly increased compared to that of nontransgenic littermates (P = 0.009) (Fig. 1A) . Consistent with increased resistance to infection, 5XFAD mice also ranked significantly higher in clinical tests grading mouse encephalomyelitis progression (P < 0.0001). 5XFAD mice also showed reduced weight loss (P = 0.0008) and lower cerebral S. Typhimurium loads (P = 0.03) compared to wild-type controls (Fig. 1, B to D) . Consistent with immunodeficiency associated with low Ab, APP-KO mice showed a trend (P = 0.10) toward increased mortality after infection (Fig. 1E) . Control injections using heat-killed bacteria did not lead to clinical decline or death in 5XFAD and wild-type mice (Fig. 1F) , consistent with mouse mortality being mediated by S. Typhimurium infection. Next, we confirmed high amounts of soluble Ab and low amounts of insoluble Ab in 4-week-old 5XFAD mouse brain using formic acid extraction and anti-b-amyloid enzyme-linked immunosorbent assays (ELISAs) (fig. S1B). To confirm that inflammation did not immunologically prime and protect 5XFAD mice against infection, we compared the immune profiles in 1-month-old transgenic and wild-type mouse brains. Consistent with previous reports showing an absence of immune activation (12) , there was no significant increase in glial fibrillary acidic protein-positive (GFAP + ) astrocytes, lba1 + microglia, and the amounts of 10 cytokines in 4-week-old 5XFAD mice compared to wild-type littermates (fig. S1, C to E).
Ab increases survival of transgenic C. elegans infected with Candida
To further explore the ability of Ab to afford protection against infection, we next tested transgenic C. elegans for resistance to Candida. Our nematode infection model uses two previously described C. elegans transgenic strains: GMC101 that expresses the 1-42 residue human Ab isoform (Ab42) (14) and CL2122, a control strain that expresses intestinal green fluorescent protein (GFP) (mtl-2:gfp) marker (as does GMC101) but does not express Ab. Adult GMC101 nematodes ultimately develop age-progressive paralysis and b-amyloid deposition in the body wall muscle. For our experiments, developmentally synchronized L4 larvae were infected 5 days before the onset of paralysis. Ab expression is driven by the unc-54 promoter (which encodes a myosin heavy chain), active in body wall muscle (14) as well as in other tissues, including muscle cells of the gastrointestinal tract (15) . Amyloidogenic peptides under the unc-54 promoter have also been shown to translocate via vesicular transport to the gut of transgenic worms, and Ab has been proposed as a likely candidate for translocation via this mechanism (16) . Immunohistological analysis of adult GMC101 using three different anti-Ab antibodies confirmed Ab localization in the body wall muscle and the gut lumen ( fig. S2, A and B) . AntiAb antibodies did not label negative control strain CL2122 intestine or body wall cells. In addition, excreta from healthy GMC101 but not CL2122 worms were positive for anti-Ab signal by immunoblot ( fig. S2C ).
Although an origin for gut Ab remains unclear, strong empirical evidence supports the localization of Ab peptides in the intestinal lumen of GMC101 nematodes. Thus, transgenic GMC101 nematodes appear to be suitable models for testing Ab-mediated protective activities against intestinal pathogens. C. albicans [American Type Culture Collection (ATCC) 90028] is an Ab-sensitive Fig. 1 . Ab expression protects against S. Typhimurium meningitis in genetically modified AD mouse models. Transgenic (5XFAD) mice expressing human Ab and mice lacking murine APP (APP-KO) were compared to genetically unmodified littermates [wild type (WT)] for resistance to S. Typhimurium meningitis. One-month-old mice received single ipsilateral intracranial injections of S. Typhimurium, and clinical progression was followed to moribundity. (A to C) Performance of 5XFAD (n = 12) mice compared to WT (n = 11) are shown after infection for survival (P = 0.009) (A), clinical score (P < 0.0001) (B), and percent weight loss (P = 0.0008) (C). (D) S. Typhimurium load 24 hours after infection in 5XFAD (n = 4) and WT (n = 4) mouse brain hemisphere homogenates shown as mean CFU ± SEM (*P = 0.03 and **P = 0.04). (E) APP-KO mice (n = 15) show a trend (P = 0.104) toward reduced survival compared to WT (n = 15) littermates after infection. (F) No mortality was observed among control sham-infected WT (n = 6) or 5XFAD (n = 6) mice injected with heat-killed S. Typhimurium. Statistical significance was calculated by log-rank (Mantel-Cox) test for survival (A, E, and F), linear regression for clinical score and weight (B and C), and statistical means compared by t test for brain bacterial loads (D). For survival and clinical analysis (A to C), data were pooled from three independent experiments. dimorphic fungus (3) and a well-characterized C. elegans intestinal pathogen that causes distention, penetrative filamentation, and death among wild-type nematodes 2 days after ingestion. Links between fungal brain infections and AD pathology have also recently emerged, including for C. albicans (17) and closely related Candida glabrata (18) . We compared survival of control CL2122 (n = 56) and GMC101 (n = 59) nematodes after incubation (2 hours, 25°C) on C. albicans lawns. Consistent with Ab-mediated protection, GMC101 nematodes infected with C. albicans showed significantly (P < 0.00001) reduced mortality as compared to control CL2122 worms that did not express Ab (Fig. 2A) . Consistent with mouse data, Ab-expressing nematodes were also protected from the C. elegans intestinal pathogen S. Typhimurium with GMC101 worms showing statistically significant (P = 0.0005) increased survival compared to CL2122 controls after infection with the bacterium (fig. S3A ).
The antimicrobial activities of Ab protects cells in culture
To address the mechanism of protection, we next tested the ability of Ab to protect cell monolayers from infection using transformed cultured human brain neuroglioma (H4) and Chinese hamster ovary (CHO) cells. H4 lines included stably transformed H4-Ab40 and H4-Ab42 cells that selectively secrete the 1-40 residue Ab isoform (Ab40) or Ab42 isoform, respectively (19) . Processing of a BRI-Ab fusion protein expressed by transformed H4 cells led to constitutive high-level expression and secretion of the encoded Ab protein.
For double transfected CHO cells (CHO-CAB), overexpression of APP and the APP-processing protease b-secretase leads to APP cleavage and the generation of multiple Ab isoforms (20) . Nontransformed H4 (H4-N) and CHO (CHO-N) cells were used as control cell lines. C. albicans has been extensively characterized Fig. 2 . Ab expression in nematodes and cultured cells increases host resistance to infection by Candida. Ab-mediated protection against C. albicans (Candida) was characterized in C. elegans and cultured host cell monolayer mycosis models. Experimental nematodes included control (Cont.) non-Ab expressing (CL2122) and transgenic (Tg) human Ab-expressing (GMC101) strains. Host cell lines included control nontransformed (H4-N and CHO-N) and transformed Aboverexpressing (H4-Ab40, H4-Ab42, and CHO-CAB) cells. (A) Survival curves for CL2122 (n = 61) and GMC101 (n = 57) nematodes after infection with Candida (P < 0.00001). (B) Viability of nontransformed and transformed host cell monolayers after 28-hour incubation with Candida. Host cell viability was followed by prelabeling host cell monolayers with BrdU and then comparing wells for an anti-BrdU signal. Signal of infected wells shown as percentage of uninfected control wells (*P = 0.002, **P = 0.001, and ***P = 0.004). (C) Candida adherence to host cells. Fluorescence micrograph of Calcofluor white-stained Candida adhering to control H4-N or transformed H4-Ab42 host cell monolayers after 2 hours of co-incubation in preconditioned culture medium. (D) Quantitative analysis of Candida host cell colonization. Adhering Candida were detected using an immunochemical luminescence assay with anti-Candida antibodies (*P = 0.003, **P = 0.001, and ***P = 0.004). Well comparisons use arbitrary luminescence units (AU). (E) Phase-contrast micrographs of agglutinated Candida after overnight incubation with H4-N or H4-Ab42 host cells. (F) Quantitative analysis of Candida agglutination. Wells were compared for yeast aggregate surface area using image analysis software (*P = 0.007, **P = 0.002, and ***P = 0.009). Bars in (B), (D), and (F) are means of six replicate wells ± SEM. Statistical significance was calculated by log-rank (Mantel-Cox) test for nematode survival (A) and statistical mean comparisons by t test (B, D, and F). Micrographs (C and E) are representative of data from three replicate experiments and multiple discrete image fields (table S1A).
in cell culture infection models and was used in our experiments as an infectious agent.
We first compared nontransformed and transformed host cells for survival after infection with C. albicans. Host cells were prelabeled with bromodeoxyuridine (BrdU). After infection, host cell viability was determined by assaying for anti-BrdU immunofluorescence. Consistent with findings for 5XFAD mice and GMC101 nematodes, survival 28 hours after infection was significantly increased for Ab-overexpressing H4-Ab40 (P = 0.002) and H4-Ab42 (P = 0.001) transformed cell lines compared to control H4-N cells, with rank order H4-Ab42 > H4-Ab40 > H4-N (Fig. 2B) . Survival of transformed CHO-CAB cells was also significantly higher (P = 0.004) than that of control CHO-N cell lines. Additional independent assays of host cell viability ( fig. S4 , A and B) were performed to confirm increased resistance of transformed H4-Ab42 cells to C. albicans infection. Attenuated C. albicans load for H4-Ab42 cells was also independently confirmed by comparing wells for yeast CFU ( fig. S4C ).
Whereas the amount of Ab in conditioned cell culture medium ( fig. S5 , A and B) fell within the physiological ranges reported for human cerebrospinal fluid (CSF) (2 to 20 ng/ml) (21), concentrations were two orders of magnitude (log 10 ) lower than the minimal inhibitory concentration (MIC) for fungicidal activities in microdilution MIC assays (3) . We have previously reported that Ab's antimicrobial activities show close parallels with those of LL-37 (3), an archetypal human AMP that remains protective at subfungicidal concentrations (22) . Two linked, yet distinct activities mediate LL-37's protective antiCandida actions at low peptide concentrations (22) . The first is disruption of C. albicans adhesion to host cells. Host cell attachment is a prerequisite step for infection by many pathogens, including C. albicans. The second is agglutination of the resulting unattached yeast cells. Agglutination limits microbial access to host cells and also generates high local AMP concentrations within peptide/microbe aggregates. Accordingly, we next tested Ab for adhesion inhibition and agglutination activities using the cell culture infection model. Hyphal C. albicans was incubated (2 hours, 37°C) in preconditioned medium with transformed or nontransformed cell cultures prepared in slide chambers. Microscopic examination revealed fewer C. albicans attached to transformed Ab-expressing cells compared to nontransformed monolayers ( Fig. 2C and fig. S6A ). To confirm these data, we repeated C. albicans-cell culture incubation experiments in 96-well microtiter plates, and we assayed the Candida load in wells immunochemically using anti-Candida antibodies. Data confirmed visual observations with statistically significant attenuation of C. albicans adhesion to transformed H4-Ab42 (P = 0.001), H4-Ab40 (P = 0.001), and CHO-CAB (P = 0.004) cells compared to naive control lines (Fig. 2D) . Additionally, after overnight incubation, marked microbial agglutination was observed in wells containing transformed, but not nontransformed, host cells (Fig. 2E and fig. S6B ). Images of wells were analyzed for yeast aggregation. Candida aggregation was significantly elevated in transformed H4-Ab42 (P = 0.00004), H4-Ab40 (P = 0.0003), and CHO-CAB (P = 0.002) samples compared to naive controls (Fig.  2F ). For H4 cell lines, adhesion inhibition and agglutination activities were consistent with host viability data, with rank orders H4-Ab42 > H4-Ab40 > H4-N.
We next characterized cell-free conditioned culture medium for Ab-mediated adhesion inhibition and agglutinating activities. Yeast adhesion and agglutination were assayed in 96-well plates using the methods of Tsai et al. (22) . Briefly, synchronized hyphal C. albicans were incubated (2 hours, 37°C) with conditioned medium samples in the absence of host cells. After washing, yeast adhering to well surfaces were stained with Calcofluor white, and fluorescence was measured. Well images were analyzed for yeast aggregation after overnight incubation. Immunodepletion with anti-Ab antibodies significantly attenuated H4-Ab42, H4-Ab40, and CHO-CAB medium adhesion inhibition (P = 0.009, P = 0.001, and P = 0.004, respectively) and agglutination (P = 0.001, P = 0.0005, and P = 0.004, respectively) activities against C. albicans (Fig. 3, A and B) . Analysis confirmed that antiAb immunodepletion removed >95% of the Ab from samples used in experiments to confirm that the anti-Candida activities of transformed cell culture medium were specific for Ab ( fig. S5, A and B) .
Consistent with yeast data, S. Typhimurium were agglutinated in H4-Ab42 conditioned medium ( fig. S3B ). H4-Ab42 cell cultures incubated with S. Typhimurium also have significantly (P = 0.036) lower intracellular infection compared to nontransformed H4-N cells ( fig.  S3, C and D) .
Serial dilution experiments showed that adhesion inhibition and agglutination activities were dose-dependent for both synthetic and cell-derived Ab (Fig. 3, C and D) . However, synthetic Ab peptide preparations had lower specific activities compared to cell-derived material. Cofactors secreted by cultured cells were unlikely to account for the increased potency of cell-derived Ab because synthetic peptide incubations were performed in Ab42-depleted conditioned medium (H4-Ab42-ID) from H4-Ab42 cell cultures. Anti-Ab antibodies used to clear Ab42 from H4-Ab42 culture medium before addition of synthetic peptides were specific for Ab and not likely to deplete species acting as cofactors. Oligomerization has been shown to modulate a range of Ab activities. Moreover, conditioned medium from experimental cell lines has been reported to contain oligomeric Ab (23), whereas our synthetic peptide preparations were pretreated to remove oligomer species. Synthetic peptide pretreatments included fractionation by preparative size exclusion chromatography to remove species >6 kD. Characterization experiments using analytical size exclusion chromatography confirmed that immediately before experimental inoculation with yeast, cell-derived material contained a polydisperse population of soluble Ab oligomers of between 8 and 50 kD, whereas synthetic peptides remained overwhelmingly monomeric ( fig. S5C ).
To test whether oligomerization modulates Ab's AMP activity, we generated synthetic Ab oligomers and compared the antimicrobial activities of Ab42 monomer, soluble oligomeric ADDLs (amyloid-bderived diffusible oligomeric ligands) (24) , and high-order protofibril (>600 kD) preparations. Compared to monomeric peptide, ADDLs exhibited potentiated, and protofibrils attenuated, adhesion inhibition ( Fig. 3E ) and agglutination ( Fig. 3F ) activities. Our data are consistent with a central role for soluble Ab low-order (2 to 30 monomer units) oligomers in mediating the peptide's AMP activities. Consistent with such a role, soluble Ab is overwhelmingly oligomeric in vivo (25) , and oligomers are key for the protective activities of a wide range of AMPs (26) (27) (28) (29) including LL-37 (26, 30) .
Antimicrobial actions are mediated by the heparin-binding activity of Ab oligomers Binding of AMP peptides to microbial surfaces is a prerequisite step for adhesion inhibition and agglutination activities. LL-37 contains an XBBXBX heparin-binding motif (where X is a hydrophobic or uncharged residue and B is a basic residue) that mediates inhibition of host cell adhesion and agglutination activities by facilitating attachment of oligomeric species (26, 30) to microbial cell wall carbohydrates (22) . Ab also contains an XBBXBX heparin-binding motif between residues 12 to 17 (VHHQKL) (31) . Competitive inhibition by soluble microbial sugars is a hallmark for AMPs with activities mediated by lectin-like carbohydrate binding (22) . Indeed, fungal and bacterial pathogens secrete specialized scavenging exopolysaccharides that target the heparinbinding domains of AMPs as a countermeasure to defenses mounted by hosts. Soluble forms of mannan and glucan, the two most abundant carbohydrates in the yeast cell wall, have been shown to inhibit XBBXBXmediated binding of LL-37 to Candida (22, 32) . We investigated whether the adhesion inhibition and agglutination activities of Ab were similarly inhibited by soluble mannan and glucan. Live yeast cells were incubated in H4-Ab40, H4-Ab42, and CHO-CAB conditioned medium in the presence or absence of mannan or glucan. Consistent with anti-Candida activity mediated by Ab's heparin-binding domain, mannan and glucan significantly attenuated adhesion inhibition (P < 0.008) and agglutination (P < 0.003) activities of conditioned medium from Ab-expressing transformed cells (Fig. 3 , G and H).
We further characterized Ab's binding to C. albicans and S. Typhimurium using a new binding immunoassay. For this assay, samples were incubated in wells containing immobilized intact hyphal Candida or S. Typhimurium cells, and bound Ab was detected immunochemically with an Ab42-specific antibody. Ab binding to Candida and S. Typhimurium was concentration-dependent ( Fig. 3I and fig.  S3E ). Consistent with binding mediated by Ab's VHHQKL domain, the anti-Ab signal from H4-Ab42 medium was significantly attenuated in the presence of glucan (P = 0.008) or mannan (P = 0.004) (Fig. 3J) . The anti-Ab signal in wells was also significantly reduced (P = 0.006) for anti-Ab-immunodepleted H4-Ab42 medium (negative control), which was consistent with assay specificity for Ab42 binding. Consistent with findings for antimicrobial activities, cell-generated Ab oligomers showed increased binding to immobilized yeast compared to synthetic monomeric peptide (Fig. 3I) . Previous studies have shown that Ab oligomerization greatly increases carbohydrate-binding activity (31) . Heparin-binding AMP oligomers also show potentiated carbohydrate binding compared to monomeric species (33) . Overall, Comparison of ID a-Ab and ID IgG medium's adhesion inhibition (*P = 0.009, **P = 0.001, and ***P = 0.004) and agglutination (*P = 0.001, **P = 0.0005, and ***P = 0.004) activities. (C and D) Comparison of anti-Candida activities of serially diluted conditioned medium and synthetic peptides. (E and F) Activities of synthetic Ab42 monomer, soluble oligomeric ADDLs, and protofibril preparations. (G and H) Conditioned culture medium adhesion inhibition (*P = 0.003 and **P < 0.0003) and agglutinating (*P < 0.02 and **P < 0.003) source activities alone (Neat) or in the presence of soluble yeast wall carbohydrates (+Glucan or +Mannan). (I) Synthetic monomeric Ab42 and cell-generated peptide from H4-Ab42 cells were compared for Candida binding using an Ab/ Candida binding ELISA. (J) Untreated, immunodepleted, or glucan (Glu)-or mannan (Man)-spiked H4-Ab42 conditioned media were incubated with intact immobilized yeast cells in an Ab/Candida binding ELISA assay (*P = 0.006, **P = 0.008, and ***P < 0.004). Synthetic peptide incubations (C to F and I) were performed in H4-Ab42 conditioned culture medium pretreated to remove cell-derived Ab by a-Ab immunodepletion. Symbols and bars for (A) to (J) are statistical means of six replicate wells ± SEM. Statistical significance was by t test.
our findings are consistent with soluble Ab oligomers having an enhanced propensity to bind to cell walls, engendering greater adhesion inhibition and agglutination activities compared to monomeric synthetic peptide.
Ab fibrillization mediates Candida agglutination
Binding by Ab of glycosaminoglycans found in brain tissue induces peptide fibrillization (34). Ab's binding of cell wall and glycocalyx carbohydrates at microbial surfaces seemed likely to also generate Ab fibrils. Although viewed solely as a part of Ab's pathophysiology, fibrillization among AMPs is a normal protective behavior that mediates antimicrobial activities, including microbial cell and viral agglutination (35) and bacterial membrane perturbation (3, 4) . Most recently, studies have shown that the human AMP a-defensin-6 (HD6) forms fibrils that entangle and trap microbial cells (36) . Thus, we next investigated a possible role for Ab fibrillization in the peptide's protective AMP activities. Analysis of earlystage (<3 hours after infection) Candida agglutination in H4-Ab42 medium using transmission electron microscopy (TEM) revealed clumped microbial cells entwined and linked by fibrils propagating from cell surfaces (Fig. 4, A to D) . C. albicans lack flagella and are not reported to produce extended fibrillar structures. Moreover, the fibrillar structures on the Candida cell surface were labeled by anti-Ab immunogold nanoparticles (anti-Ab-Au). AntiAb-Au binding to fibrils was ablated by co-incubation with synthetic Ab peptide, consistent with Ab-specific labeling (Fig. 4D) . TEM analysis of early-stage S. Typhimurium agglutinates in H4-Ab42 conditioned medium confirmed that bacterial cells were also bound and linked by fibrils ( fig. S3F ).
Epifluorescence micrographs of Thioflavin S-stained late-stage (>12 hours after infection) H4-Ab42 yeast aggregates displayed the enhanced fluorescence and red shifts that mark the presence of amyloid fibrils (Fig. 5A) . Enhanced fluorescence was not observed for negative control yeast agglutinates (Fig. 5A) . Thioflavin S fluorescence within H4-Ab42 yeast aggregates colocalized with the signal for anti-Ab immunoreactivity (Fig.  5B) . Congo red-stained H4-Ab42 yeast aggregates also showed birefringence under polarized light, another marker for b-amyloid ( fig. S7 ). Scanning electron microscopy (SEM) micrographs of yeast aggregates from H4-Ab42 medium revealed an irregular material adhering to cell surfaces not present in Candida pellets prepared by centrifugation in Ab-free medium (Fig. 5C) . Analysis of the Candida cell surface by TEM revealed the adhering material to be filamentous and immunoreactive to anti-Ab-Au (Fig. 5D ). Co-incubation of soluble synthetic Ab40 peptide abolished anti-Ab-Au binding. Collectively, the data are consistent with microbial agglutination and entrapment mediated by Ab fibrillization in our cell culture infection model. b-Amyloid mediates pathogen entrapment in GMC101 nematodes and 5XFAD mice We also investigated infection-associated Ab fibrillization in our nematode and mouse infection models. Consistent with Ab targeting and binding to yeast cells in our cell culture model, Candida in the gut of recently infected (2 hours after ingestion) GMC101 nematodes were labeled by anti-Ab-Au nanoparticles (Fig. 6A) . Yeast cells in the gut of the control CL2122 nematode were not labeled by anti-Ab-Au ( fig.  S8A ). Ab fibrillization in GMC101 worms is normally confined to the body wall muscle. However, compared to infection-free nematodes, (table S1A) .
GMC101 worms with late-stage Candida infection showed enhanced Thioflavin S fluorescence in nonmuscle tissue, including the gastrointestinal tract (Fig. 6B) . High-resolution micrographs of yeast cells in the gastrointestinal tract of GMC101 nematodes revealed clumped Candida embedded in the material that showed enhanced fluorescence after Thioflavin S staining (Fig. 6C) and was labeled by anti-Ab antibodies (Fig. 6D) . Consistent with Ab-specific labeling, anti-Ab signal ( fig. S2B ) and enhanced Thioflavin S fluorescence (fig. S8B) were absent from uninfected or Candida-infected negative control CL2122 nematodes that did not express Ab. Findings for C. albicans-infected GMC101 nematodes were consistent with the agglutinating and entrapment roles of Ab fibrils observed in our cell culture infection models. Thus, Ab fibrillization on the surface of yeast cells infecting the gut of GMC101 nematodes may mediate the resistance to infection observed for these worms.
Four-week-old 5XFAD mouse brain is normally negative for b-amyloid deposits (12) . However, Thioflavin S and anti-Ab staining of 5XFAD mouse brain revealed widespread b-amyloid deposition 48 hours after infection with S. Typhimurium (Fig. 7, A and B) . Moreover, anti-Salmonella and b-amyloid signal colocalized in the 5XFAD mouse brain, suggesting that bacterial cells may have induced Ab fibrillization. TEM analysis also revealed that bacterial cells were embedded in fibrous material labeled by anti-Ab-Au nanoparticles in 5XFAD but not wild-type mouse brain sections ( fig. S8) . A video of Z-section projections rotating through 360°shows that bacteria are not confined to the surface of Ab accretions but are embedded within the b-amyloid deposits (video S1). Consistent with fibrillization driven by proliferation of S. Typhimurium cells, b-amyloid deposits were absent from sham-infected 1-month-old 5XFAD control mice injected with heat-killed bacteria. Thioflavin S staining and anti-b-amyloid antibodies did not label mouse brain from negative control nontransgenic littermates (Fig. 7A ).
DISCUSSION
Our findings are consistent with a potential protective role for Ab in vivo as an AMP. Expression of Ab was associated with increased host survival in cell culture, nematode, and mouse infection models ( Figs.  1 and 2 ). Low Ab expression was associated with higher mortality after infection of APP-KO mice. Our data are consistent with a protective role for Ab in innate immunity that uses a classic AMP mechanism characterized by reduced microbial adhesion to host cells and agglutination and entrapment of microbes by Ab fibrils. Moreover, wellcharacterized Ab activities mediate the peptide's antimicrobial actions. However, these same properties, oligomerization, fibrillization, and carbohydrate binding, are also linked to Ab's pathophysiology. Whereas a protective/damaging duality is a new proposition for Ab's activities, this is not the case for classical AMPs. For example, LL-37 offers a germane model for the potential pathological consequences of normally protective AMP actions. LL-37 is essential for normal immune function, and low expression leads to lethal infections (37) . However, at elevated concentrations, LL-37 is cytotoxic to host cells, particularly smooth muscle cells (38) . The cytotoxic and proinflammatory activities of LL-37 are implicated in the pathogenesis of several major late-life diseases, including rheumatoid arthritis, lupus erythematosus, and atherosclerosis (39) . Thus, a normally protective Ab activity spectrum that, when dysregulated, also leads to AD pathology is consistent with the actions of classical human AMPs.
Adhesion blocking and agglutination activities are distinct from AMP microbicidal activities, which typically require micromolar concentrations of peptide and involve different mechanisms (22) . The adhesion inhibition and agglutination activities that we observed in vitro for cell-derived Ab (Fig. 3) fall within physiological concentration ranges reported for normal human CSF (1 to 5 ng/ml). Consistent (table S1A) .
with a normal in vivo protective role, the highest cerebral concentrations of Ab are in the leptomeninges (10 to 50 ng/ml) (40), the brain's first line of defense against infection and a tissue enriched for LL-37 and other innate immune proteins (41) . The high specific activity observed for cell-derived material is consistent with our previous finding that Ab in human brain extracts is a potent anti-Candida agent (3). Classical AMP expression can be either constitutive or inducible (5) 
In in vitro assays, cell-derived and synthetic Ab oligomers were more potent against Candida than were monomeric forms (Fig. 3, C to F, and  fig. S5C ). The specific activities of synthetic ADDLs, although higher than nonoligomerized peptide, remain lower than cell-derived Ab species. Peptide posttranslational modifications may enhance the AMP activity of cell-derived Ab oligomers. However, oligomer conformation is also likely to play a key role. Neurotoxicity has been shown to be highly dependent on the arrangement of Ab peptides within oligomeric assemblies. Oligomer morphology may also modulate Ab's protective antimicrobial activities. Protocols for preparing ADDLs and other synthetic Ab assemblies are optimized for oligomer populations with neurotoxic, not antimicrobial, activities. Future protocols optimized for enhanced AMP activities may generate soluble synthetic Ab oligomers with potencies that approach that of cell-derived material.
Ab pathophysiology is thought to arise from an abnormal propensity to generate soluble oligomers. However, oligomerization is not a pathogenic behavior for AMPs, and it plays a key role in normal protective activities across this diverse group of proteins, including microbe agglutination and entrapment (35) , the targeting (26, 30) and disruption of microbial cell membranes (4, 46), resistance to bacterial proteases (26, 27, 46) , and expanding of the molecular diversity and protective functions of AMP families without commensurate genome expansion (28, 29) . Our data and the widespread involvement of oligomerization in the protective actions of AMPs suggest that the brain's pool of soluble Ab may normally include physiologically functional oligomeric species that mediate protective antimicrobial activities. The intrinsic polymorphic stoichiometry of Ab oligomers may also play a protective physiological role. As has been shown with classical AMPs, diverse polymorphic oligomer pools target a broader spectrum of pathogens and are more resistant to AMP-targeting microbial proteases than are homogeneous peptide populations.
The lectin activity of Ab oligomers is thought to promote brain amyloidosis (34) . Studies to date have focused on accelerated Ab fibrillization induced by binding of endogenous brain proteoglycans and glycosaminoglycans. However, our findings suggest that Ab oligomers also bind to microbial carbohydrates with high affinity (Fig. 3, G to J) . Carbohydrate-binding activity among AMPs is widespread and normally protective, playing a key role in helping peptides to recognize and bind to microbial pathogens (22) . Heparin-binding AMPs have high affinities for the unique microbial carbohydrates found in cell walls but also bind to host glycosaminoglycans (47) . Consistent with our findings for Ab, binding of classical AMPs to microbial carbohydrates can lead to rapid peptide fibrillization and amyloid-mediated antimicrobial activities (48) . Dysregulated carbohydrate binding by Ab may play a role in AD amyloidogenesis. However, a normal role as an AMP would suggest that polymeric microbial cell surface carbohydrates may be the normal in vivo target for the heparin-binding activity of oligomeric Ab species.
Long recognized as a key defensive strategy among lower organisms, AMP-mediated microbial agglutination is also emerging as an important part of human immunity (49) . AMP fibrillization appears to play a central role in this important protective activity (35) . Most recently, in vivo fibrillization of HD6 has been shown to mediate not only agglutination but also microbial entrapment within an amyloid fibril network (36) . Our findings suggest that fibrillization is also involved in Ab-mediated agglutination and leads to the entrapment of microbial cells by Ab fibrils. On the basis of our findings, we propose a three-stage model for the protective activity of Ab in vivo. Our model parallels the agglutination and entrapment actions of amyloidogenic HD6 (36) . First, the VHHQKL heparin-binding domain of Ab mediates targeting and binding of soluble oligomeric species to cell wall carbohydrates ( fig. S10A ). Bound oligomers then provide a nidus and anchor for Ab fibril propagation. Second, growing protofibrils interfere with microbial adhesion to host cells ( fig. S10B) . Third, Ab fibrils link, agglutinate, and then entrap the unattached microbial cells in a protease-resistant network of b-amyloid ( fig. S10C) . Consistent with our model for the antimicrobial activities of Ab, classical human AMPs have also been shown to generate amyloid fibrils on microbial surfaces that agglutinate pathogens and inhibit infection (35) .
Consistent with our AMP model for Ab, APP-KO mice show a trend for reduced pathogen resistance (Fig. 1E) . However, the increase in infection-driven mortality among APP-KO mice was less marked than the increase in survival observed in the 5XFAD mouse model (Fig. 1A) . For AMP-deficient models, immune impairment is often moderate because redundant activities among related members of AMP families can partially offset the loss of protection associated with low expression of individual AMP species (50) . The well-studied human AMP LL-37 that serves as our model for Ab's AMP activity (3) is a member of the cathelicidin protein family. In humans, serious immunodeficiency associated with low LL-37 expression typically leads to fatal infections in childhood if untreated (37) . However, mice lacking the murine LL-37 precursor protein (mCRAMP) show only a modest increase in mortality (≈10%) due to bacterial meningitis (51) . Conversely, survival with infection among transgenic mice overexpressing human LL-37 is increased several-fold (52) . APP-KO mice generate at least two Ab homologs from amyloid precursor-like protein 1 (APLP1) and 2 (APLP2), which may help to mitigate loss of Ab-mediated protection (53) . Consistent with this model, APP, APLP1, and APLP2 and their nonamyloidogenic processing products show extensive functional redundancy (54) , likely because of the gene duplication origin for this protein family. APP-KO mice also have an important additional limitation as models for the loss of Ab-mediated protection. APP itself may be involved in central nervous system (CNS) immunity (55) . It remains unclear how loss of activities normally mediated by full-length APP can be excluded as the source of attenuated infection resistance in APP-KO mice.
Genetically modified mice that lack proteases [BACE1 (b-site APP cleaving enzyme 1) and BACE2] for generating the Ab family of peptides provide an alternative Ab-null model. Consistent with our data, knockout BACE-KO mice that lack BACE have been reported to have marked immunodeficiency. Whereas neonatal mortality is below 2% under sterile conditions, in less stringently antiseptic environments, up to half of pups born to BACE-KO mice die from infections within the first 2 weeks of life (56) . Benchmark tests for adaptive immunity have failed to identify defects in the response of BACE-KO mice to immune challenges. Findings for BACE-KO mice appear consistent with an innate immune deficiency and a possible normal protective role for Ab. However, as with APP-KO mice, it is unclear how to demonstrate that the immunodeficiency in BACE-KO mice is specific for a loss of members of the Ab family of peptides. Additional data are required to conclusively link the etiology of BACE-KO mouse immunodeficiency to low Ab. Our findings for Ab and b-amyloid may have corollaries for amyloidopathies beyond AD. Protein fibrillization may be important not only for Ab's AMP activities but also for the normal actions of other amyloidosis-causing proteins. An association between amyloidosis and chronic bacterial infections has been recognized for almost a century (57) , but the potential protective activities of host-generated amyloid have only recently emerged (4, 35, 58) . At least six amyloidosisassociated peptides show antimicrobial activities, including amylin (59), atrial natriuretic factor (9), prion protein (60), cystatin C (61), lysozyme (5) , and superoxide dismutase (62) . Conversely, host AMPs have been identified that generate protective amyloids localized to infection sites (4) . AA-type amyloidosis involves both systemic deposition of the acute-phase opsonin AMP serum amyloid A and has an infection-driven etiology (63) . It remains to be determined whether serum amyloid A or other amyloidosis-causing AMPs also engage in nonpathogenic fibrillization pathways that help to protect against infection. However, should this prove to be the case, Ab may be the first member of a new class of AMPs in which amyloid-generating activities protect against local infections but can also lead to widespread pathological amyloidosis.
If confirmed, our model carries important implications for understanding the pathogenesis of amyloidosis in AD. Excessive b-amyloid deposition may arise not from an intrinsically abnormal propensity of Ab to aggregate but instead may be mediated by dysregulation of the brain's innate immune system, for example, the consequence of an immune response mounted to microbial or sterile inflammatory stimuli. Our new model is congruent with the amyloid hypothesis and the importance of Ab and b-amyloid in the neurodegenerative cascade of AD. However, our model would shift the modality of Ab's pathophysiology from abnormal stochastic behavior toward dysregulated antimicrobial activities.
Our study used genetically modified cell and animal models to generate data consistent with a normal physiological role for Ab as an AMP. However, it remains unclear from these data how important a role Ab plays in normal infection resistance. To address this question, additional data will be needed from wild-type animals modeling common physiological routes of infection. Further investigation will also be needed to clarify the extent to which the normal antimicrobial activities of Ab identified in our study affect AD pathology.
It is important to emphasize that although infection of 5XFAD mice with S. Typhimurium seeded and accelerated b-amyloid deposition, the presence of a CNS infection is not implicit in our proposed AD amyloidosis model. Our work has identified what we believe is the normal role of Ab. What drives widespread b-amyloid deposition in AD remains unclear. Among sterile inflammatory diseases, dysregulated innate immune responses rather than infections are emerging as drivers of pathology. Notably, two of the three confirmed AMP amyloidopathies are not linked to obvious infections (4, 9, 64). However, a large body of data accrued over nearly a century suggests that genuine infection may also play a role in AD etiology (65) . Moreover, although a causal link to amyloidosis remains to be conclusively demonstrated, recent epidemiological findings have given increased prominence to the "infection hypothesis," including studies linking brain fungal infection to AD (17, 18) and data showing that risk for the disease increases with infectious burden (66) . Our findings do not constitute direct evidence of a role for infection in AD etiology. However, they do suggest a possible mechanism for pathogen-driven b-amyloid amyloidosis. Our data also suggest the possibility that a range of microbial organisms may be able to induce b-amyloid deposition, a possible reason for why a single pathogen species has not yet been identified that is overwhelmingly associated with AD. Future studies systematically characterizing microbial pathogens (viral, bacterial, and fungal) in the brains of AD patients, for example, by RNASeq, will be necessary to further interrogate whether specific clinical pathogens seed b-amyloid as part of the brain's innate immune system. In any case, whether infectious or sterile inflammatory stimuli drive AD pathology, the pathways that regulate innate immunity in the brain may offer significant new targets for therapeutic intervention.
MATERIALS AND METHODS

Study design
Protective activities associated with Ab expression were investigated in murine, nematode, and cell culture models of infection. Transgenic mice, nematode, and cell culture models were used that constitutively express human Ab at high levels. Experiments also included a null-Ab mouse model. Modulation of infection resistance with peptide expression is considered a hallmark for identity as an AMP. Initial experiments tested for Ab-mediated increase (high-expression models) or decrease (null-Ab mice) in survival after infection. End points were death for cultured cells and nematodes and moribundity for mice in accordance with Institutional Animal Care and Use Committee guidelines. Experiments were conducted blind as to cell, nematode, and mouse genotypes. The mechanism of protection afforded by high Ab expression was then characterized in our cell culture monolayer infection model. We have previously shown parallels between Ab activities and LL-37, a highly characterized human AMP. LL-37 was used as a model to elucidate the mechanisms for Ab targeting, adhesion inhibition, and agglutination activities against microbial cells. Finally, nematode and mice models were tested to confirm in animals the potential protective microbial entrapment role of Ab fibrillization revealed by cell culture experiments. Figure legends include details of replicate experiments used to generate data sets.
Monomeric and oligomeric synthetic peptide preparation Synthetic Ab1-40 (Ab40), Ab1-42 (Ab42), scrambled Ab42 (scAb42), and LL-37 peptides were prepared and purified by J. I. Elliott at Yale University (New Haven, CT) using solid-phase peptide synthesis. Bulk powdered Ab peptides were initially dissolved and incubated (18 hours) at room temperature (RT) in 30% trifluoroethanol (1 mg/ml) before lyophilization and storage (−20°C) under nitrogen. Before experimentation, dried peptide films were solubilized in 10 mM NaOH. For preparation of monomeric Ab stocks, peptide solutions were diluted into phosphate-buffered saline (PBS) and fractionated by size exclusion chromatography, and peak monomer fractions (3 to 6 kD) were pooled. Monomer stocks were stored on ice at 100 mM and used within 2 hours of preparation. Synthetic Ab42 oligomer preparations (ADDLs and protofibrils) were generated from NaOH peptide stocks using established protocols (67) . Peptide concentrations in stock solutions were determined by bicinchoninic acid protein assay and confirmed in experimental serial dilutions by densitometry analysis of anti-Ab immunoblots.
Candida inoculants and lawns
Freezer stocks of C. albicans strain 90028 were obtained from the ATCC. C. albicans stocks were maintained on yeast extract peptone dextrose (YPD) agar at 4°C with subculture to fresh plates every 2 weeks.
C. elegans pathogenicity plates were prepared by streaking (10 ml) sterile 35-mm tissue culture plates (BD Falcon) with yeast grown overnight (30°C) in YPD broth. Plates were incubated at 25°C for 2 hours to generate C. albicans lawn.
Synchronized hyphal yeast for cell culture experiments were prepared by single-colony transfer of C. albicans stock to 5 ml of minimal sugar medium (Formedium) and 48-hour static incubation at RT (68) . After pelleting (1750 relative centrifugal force for 2 min) and PBS washing, starved yeast were resuspended in RPMI 1640 medium (HyClone) and concentration was adjusted to 2.5 × 10 6 cells/ml. Stock yeast in RPMI were diluted 10-fold into unconditioned culture medium immediately before inoculation of host cell slide or culture plate wells. Yeast concentration in inoculates was determined using a Bio-Rad TC20 automated cell counter and confirmed by counting CFU after serial dilution and streaking on agar.
S. Typhimurium inoculants S. enterica serotype Typhimurium SL1344 stocks were provided by B. Cherayil (Mucosal Immunology Department, Massachusetts General Hospital, Boston, MA). Colonies were maintained on agar and subcultured to fresh plates every 3 weeks. Inoculant stocks were prepared by single S. Typhimurium colony to transfer to Luria-Bertani agar with streptomycin (100 mg/ml) and incubation overnight in a shaker incubator (225 rpm at 37°C). After PBS washing, pelleted (10,000g × 2 min) bacteria were resuspended in inoculation medium and diluted to required concentration. Bacterial concentrations in stocks were determined by comparing inoculum turbidity to McFarland turbidity standards and confirmed by streaking on agar and counting CFU.
For mouse experiments, S. Typhimurium inoculants were pathologized before infection by incubation in Luria broth with streptomycin (100 μg/ml) overnight at 37°C. Pathogenicity plates for C. elegans were prepared by streaking inoculate (10 ml) onto Pseudomonas aeruginosaand S. enterica-killing assay plates and overnight incubation at 37°C. For host cell monolayers, inoculant was added directly to culture medium.
Immunodepletion
Protein G Plus Agarose slurry (Pierce) was pelleted, washed, and incubated for 2 hours at RT with 4G8 (epitope: Ab17-24) monoclonal antibody (mAb) (Covance) or control mouse IgG in PBS. After washing, beads were incubated with medium samples for 2 hours at RT under conditions equivalent to 10 mg of antibody per milliliter of medium. Beads were pelleted, and soluble fractions were removed, filtered (0.2 mm), and assayed to confirm Ab depletion.
Ab binding ELISA
The wells of 96-well plates were coated with live yeast by overnight incubation (37°C) with synchronized C. albicans (50 to 250 CFU per well) in RPMI medium (200 ml per well). Wells were washed to remove unattached yeast, and adhering C. albicans cells were then killed and covalently fixed in place by incubation (15 min at RT) with 4% paraformaldehyde. Wells were blocked (2 hours at RT) with 2% bovine serum albumin (BSA) in PBS before incubation with experimental samples. Bound Ab in wells was detected immunochemically by incubation (overnight at 4°C) with a-Ab42-HRP (horseradish peroxidase) (Covance) diluted 1:1000 in blocking buffer and development with 100 ml of chemiluminescence reagent (Pierce). Wells were washed (five times) with PBS between incubations.
Mouse infection model
Female 5XFAD (12) APP/PS1 doubly transgenic mice co-overexpress and co-inherit FAD mutant forms of human APP (the Swedish mutation: K670N/M671L; the Florida mutation: I716V; the London mutation: V717I) and PS1 (M146L/L286V) transgenes under transcriptional control of the neuron-specific mouse Thy-1 promoter (Tg6799 line). 5XFAD lines (B6/SJL genetic background) were purchased from The Jackson Laboratory and maintained by crossing heterozygous transgenic mice with B6/SJL F1 breeders. All 5XFAD transgenic mice were heterozygotes with respect to the transgene. Animal experiments were conducted in accordance with institutional and National Institutes of Health guidelines.
One-month-old mice received a single injection of 65,000 CFU (0.18 to 0.20 ml) of S. Typhimurium suspension at anterior/posterior, −1.6; medial/lateral, +1.5; dorsal/ventral, −1.6/−1.1/−0.7 using a 5-ml Hamilton syringe with a 30-gauge needle attached to a digital stereotaxic apparatus and an infusion pump at a rate of 0.15 ml/min. After infusion was completed, the needle remained in place for 10 min before slow withdrawal. Mice were given food and water on the cage floor starting 24 hours after the injection. Control sham infections used S. Typhimurium heat-killed before injection.
Clinical scores were recorded every 8 hours according to modified grading criteria for mouse encephalomyelitis (69, 70) . Clinical criteria are summarized in fig. S1A . Clinical progression was followed to moribundity, and then mice were sacrificed. Scores were recorded for each mouse and expressed as means ± SEM.
Mouse tissue preparation and sectioning For immunofluorescence, mice were deeply anesthetized with a mixture of ketamine and xylazine and perfused transcardially with 4% paraformaldehyde in cold PBS. Brains were postfixed overnight and then transferred into a 30% sucrose solution until sedimented. Coronal sections (40 mm) were cut from an ice-cooled block using a sliding microtome (Leica). Sections were stored at −20°C in cryoprotective buffer containing 28% ethylene glycol, 23% glycol, and 0.05 M phosphate until processing for analysis.
Immunofluorescence labeling of mouse sections
Immunofluorescence labeling was performed as previously described (12) . Primary antibodies include rabbit anti-GFAP (1:500, Dako) for astrocytes, rabbit anti-ionized calcium-binding adaptor molecule 1 (Iba1, 1:500, Wako) for microglia, and anti-Salmonella polyclonal rabbit for S. Typhimurium. Bound primary antibodies were detected with anti-rabbit Alexa Fluor 594 (Invitrogen, 8889S). Cell nuclei in sections were stained with TO-PRO-3 iodide (1:500, Life Technologies).
Immuno-and Thioflavin S-costained mouse sections
Immunofluorescence labeling was performed as described previously (71) . Briefly, sections were incubated with primary anti-Salmonella polyclonal rabbit IgG (1:1000) (PA1-7244, Thermo Fisher Scientific), followed by secondary anti-rabbit Alexa Fluor 594 (1:500) (Invitrogen, 8889S) antibodies. For Ab staining, sections were incubated with mouse mAbs 3D6 (Eli Lilly) (mouse brain sections) or 4G8 (nematode sections). Bound anti-Ab antibodies were detected by incubation with anti-mouse Alexa Fluor 488 (1:500) (Life Technologies, A11001) antibodies (Invitrogen). After immunostaining, free-floating sections were incubated (8 min) with 0.002% Thioflavin S in tris-buffered saline (TBS), rinsed twice for 1 min in 50% methanol washed for 5 min in TBS, and mounted with ProLong Gold antifade reagent (Life Technologies). Stained sections were analyzed by CFM (Leica TCS SL, Leica Microsystems). C. elegans model Two previously described transgenic C. elegans strains were used in experiments. GMC101, dvIs100 [pCL354(unc-54:DA-Aß1-42) + pCL26 (mtl-2: GFP)] nematodes express human Ab42 in body wall muscle and GFP in intestinal cells (14) . Control C. elegans CL2122 dvIs15(mtl-2: GFP) nematodes express GFP but not the Ab42 peptide (14) . Worms were synchronized before experimental treatments according to established protocols (72) . Briefly, unhatched eggs were released by treating gravid worms with bleach. After an overnight incubation, arrested L1 larvae were added to Escherichia coli OP50 lawns and incubated at 20°C to generate synchronized L4 larval (48 hours) or adult (60 hours) nematodes.
For infection experiments, 100 to 150 synchronized L4 stage worms were incubated (2 hours at 25°C) on C. albicans lawns, washed with M9 buffer to remove surface C. albicans, and transferred to six-well culture plates containing 1.5 ml per well of incubation medium [79% M9 buffer, 20% brain-heart infusion, cholesterol (10 mg/ml) in ethanol, and kanamycin (90 mg/ml)]. Nematodes were incubated at 25°C and monitored daily for the distinctive distention and penetrative filamentation that characterize Candida-induced mortality.
Nematode freeze-fracture and immunostaining Worms (L4) were transferred dropwise to poly-lysine-coated slides and covered with a coverslip. Gentle pressure was applied to the coverslip before the slide assembly was placed on a metal block and flashfrozen using liquid nitrogen. The coverslip was flicked off, and fractured samples were fixed by 5-min incubations with absolute alcohol, followed by acetone. Dried samples were ringed with petroleum jelly and covered with a second coverslip. Slide staining was performed in a wet chamber. For immunostaining, slides were blocked for 15 min with blocking buffer [10% Tween and powdered milk (0.2 g/ml) in PBS] and then incubated (1 hour at RT) with rabbit polyclonal antiCandida antibody (Abcam, ab20028) and/or anti-Ab mAb 4G8. After washing, slides were incubated with anti-rabbit and/or anti-mouse antibodies conjugated to Alexa Fluor 568 and Alexa Fluor 488 fluorescent dyes (Life Technologies), respectively. For Thioflavin S staining, slides were incubated for 1 hour at RT with dye solution and PBSwashed. Specimens were incubated with ProLong Gold antifade reagent (Life Technologies) before viewing by CFM.
Host cell monolayer model
Host cell monolayers were prepared from nontransformed and transformed human neuroglioma (H4) or CHO cell lines. Stable transformed H4 cell lines that secrete Ab40 (H4-Ab40) or Ab42 (H4-Ab42) without overexpression of the APP have been described previously (19) . Stable transformed CHO-CAB cells coexpressing human ATCC Swedish mutation and BACE1 were generated by transfecting a pcDNA3.1-BACE1-myc construct into CHO-APP751 cells that overexpress mutant APP751 (K670N/M671L: Swedish mutation) (20) .
Nontransformed H4-N and CHO-N cell lines were maintained in complete medium containing Dulbecco's modified Eagle's medium (DMEM), 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U penicillin, and streptomycin (100 mg/ml). Complete medium for transformed H4-Ab40 and H4-Ab42 cells included hygromycin (150 mg/ml) and media for CHO-CAB Zeocin (200 mg/ml) and G418 (200 mg/ml).
To prepare experimental HCMs, trypsinized host cells suspended in antibiotic-free DMEM with 5% FBS and 2 mM L-glutamine were transferred (300,000 and 500,000 cells/ml for H4 and CHO lines, respectively) to the wells of Lab-Tek eight-chamber glass slides (Thermo Scientific) (200 ml per well) or 96-well culture plates (100 ml per well) and incubated for 24 hours. Cell confluence in chamber slides and plate wells was confirmed by microscopic examination. Automated cell counter analysis of well trypsin extracts confirmed that, in control uninfected cell monolayers, nontransformed and transformed cell numbers did not diverge by more than 6% before infection or after the final experimental incubation (fig. S4D ).
Nontransformed and transformed culture media were conditioned for 36 hours before inoculation with Candida. HCMs in culture plates were infected by addition of Candida inoculant aliquots (10 ml) containing 2000 or 250,000 CFU, respectively. For host cell survival experiments, Candida were incubated with H4 and CHO cells for 28 and 36 hours, respectively. HCMs were then washed and assayed for host cell survival.
Host cell BrdU labeling Subconfluent nontransformed and transformed H4 and CHO cells were incubated overnight (10-cm culture dishes) in complete culture medium containing 10 mM BrdU. Confluent BrdU-labeled cell cultures were PBS-washed (three times) to remove free BrdU, then trypsinized, and used for preparation of HCMs in 96-well culture plates. After experimental treatments, plate wells were washed with PBS (three times), then fixed and permeabilized, and assayed according to the manufacturer's instructions (Cell Proliferation BrdU ELISA, Roche).
Imaging C. albicans host cell adherence Cell monolayers in eight-well chamber slides were infected with synchronized hyphal yeast (10,000 CFU per well) by addition of a 10-ml aliquot of freshly prepared C. albicans inoculate to culture medium (200 ml per well) preconditioned for 36 hours with host cells. Infected slides were incubated for 2 hours, medium was removed by aspiration, and wells were washed with PBS (three times) and then fixed by 10-min incubation with 4% paraformaldehyde. Fixative was removed, and wells were washed (three times) before incubation (30 min) with Calcofluor white M2R fungal surface stain (Life Technologies) (73) . Wells were water-washed and coverslipped before imaging by fluorescence microscopy (excitation, 360 nm/emission, 460 nm).
Immunochemical detection of C. albicans adhering to cell monolayers Experiments were performed using HCMs prepared in white opaque 96-well culture plates. HCMs were infected with synchronized hyphal yeast (1000 CFU per well) by addition of 10 ml of freshly prepared C. albicans inoculate to wells containing preconditioned (36 hours) culture medium (100 ml per well). Wells were incubated 18 hours with yeast before aspiration of medium, gentle washing with PBS (three times), and fixation by 10-min incubation with 4% paraformaldehyde. Fixative was removed, and wells were washed (three times) before incubation (1 hour) with blocking buffer [2% albumin in tris-buffered saline-Tween 20 (TBST)]. Wells were then incubated (2 hours) with fresh blocking buffer containing a 1:5000 dilution of a-Candida-HRP antibody (Abcam). Wells were washed with TBST (five times) and fluorescent-captured (excitation, 320 nm/emmision, 420 nm) after development with QuantaBlu (Pierce), a fluorescent HRP substrate.
C. albicans adhesion assay for abiotic surfaces Experiments used a modified method of Tsai et al. (22) to assay C. albicans adhesion to polystyrene in conditioned culture medium. Synchronized hyphal yeast (1000 CFU per well) were incubated (37°C) in the wells of clear, flat-bottom polystyrene 96-well microtiter plates containing host cell-conditioned (36 hours) culture medium (200 ml per well). Incubation medium was removed by aspiration, and wells were washed (three times) before incubation (30 min at RT) with PBS (200 ml per well) containing 10 ml of Calcofluor white fungal stain solution 6726 (Eng Scientific). After washing, attached hyphae were detected by measuring well fluorescence (excitation, 360 nm/emmision, 460 nm).
C. albicans aggregation assay
Host cell-conditioned (48 hours) culture medium (200 ml per well) was incubated (overnight at 37°C) with synchronized yeast (200 cells per well) in the wells of clear 96-well microtiter plates. Incubation medium was removed, and yeast pellets were washed twice with PBS. During aspiration, care was taken to minimize disturbance of settled yeast at the well bottom. Settled yeast pellets were resuspended in PBS and transferred to fresh wells. Low-magnification (×4) bright-field well images were captured at maximum condenser aperture. Images were then analyzed for yeast aggregates using ImageJ software (version 1.47) with the following procedure. Captured image files were first converted from 8-bit RGB to 8-bit grayscale and then further transformed to 1-bit black and white images using a conversion threshold of 86%. Well area covered by yeast aggregates was determined from pixel counts of transformed black and white images using the Analyze Particle tool with lower size threshold set to 50 pixels. Isolated black areas of less than 50 pixels (four to six yeast cells) were not included in aggregate totals.
Staining and antibody labeling of C. albicans aggregates Aggregated yeast were pelleted (2 min × 500g), washed with PBS (twice), and transferred to glass slides in minimal volume, and excess buffer was blotted off. Slides were air-dried to fix yeast and then carefully rinsed with water. For dye staining, slides were incubated in the dark at RT with 50 ml of Thioflavin S (5 min) or staining solution and then water-rinsed. For immunolabeling experiments, specimens prestained with Thioflavin S were incubated (2 hours at 4°C) with blocking buffer containing 1:1000 dilution of mAb 4G8. Slides were TBST-rinsed and then incubated (1 hour at RT) with donkey antimouse IgG antibody covalently labeled with the red fluorescent dye Alexa Fluor 594 (a-mouse-AF568) (Life Technologies). Thioflavin and anti-Ab double-labeled specimens were mounted with Prolong Gold antifade reagent (Life Technologies) before viewing with a fluorescence confocal microscope (Leica TCS SL, Leica Microsystems).
TEM of microbial agglutinates
Candida aggregate cells suspended in PBS (5 ml) were absorbed to Formvar carbon-coated copper grids (FCF100-Cu, Electron Microscopy Sciences). Grids were blocked with 1% BSA in PBS (kept covered for 10 min at RT) and then incubated (30 min at RT) with mAb 4G8 diluted 1:1000 in blocking buffer. The grids were washed with PBS (three times) and incubated with goat anti-mouse IgG antibody covalently linked to nanogold particles. After three 5-min PBS washes and four 10-min water washes, specimens were fixed with 1% glutaraldehyde (10 min at RT). Specimens were washed with water, stained with uranyl acetate, and then viewed using a JEM-1011 transmission electron microscope (JEOL Institute).
Statistical analysis
Statistical analyses were performed with Prism software (version 6.0c). Arithmetic means were compared using two-tailed t tests. Survival curves were compared using log-rank (Mantel-Cox) test and confirmed by Gehan-Breslow-Wilcoxon test. P values <0.05 were considered statistically significant.
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